Description

BSE lists 13,05,400 new equity shares of Vipul Organics Limited for trading effective March 16, 2026, issued on a preferential basis to non-promoters at Rs. 211/- per share.

Summary

BSE has notified trading members that 13,05,400 new equity shares of Vipul Organics Limited (Scrip Code: 530627) are listed and permitted to trade on the Exchange with effect from Monday, March 16, 2026. These shares were issued on a preferential basis to non-promoters at an issue price of Rs. 211/- per share (face value Rs. 10/- + premium of Rs. 201/-).

Key Points

  • Total new shares listed: 13,05,400 equity shares of Rs. 10/- each
  • Issue price: Rs. 211/- per share (Rs. 10 face value + Rs. 201 premium)
  • Allotted to: Non-Promoters on a preferential basis
  • Date of allotment: 22 December 2025
  • Trading effective from: Monday, March 16, 2026
  • ISIN: INE834D01018
  • Distribution numbers: 17749167 to 19054566
  • Shares rank pari-passu with existing equity shares of the company

Regulatory Changes

No regulatory changes. This is a standard listing notification for newly allotted preferential shares.

Compliance Requirements

  • Trading members must note the lock-in restrictions on the newly listed shares before executing trades
  • Shares under lock-in cannot be traded until the respective lock-in expiry dates

Important Dates

EventDate
Date of Allotment22 December 2025
Trading commences16 March 2026
Lock-in expiry (12,15,000 shares: Dist. 17749167–18964166)30 October 2026
Lock-in expiry (60,000 shares: Dist. 18964167–19024166)31 October 2026
Lock-in expiry (20,000 shares: Dist. 19024167–19044166)30 October 2026
Lock-in expiry (10,400 shares: Dist. 19044167–19054566)31 October 2026

Impact Assessment

The listing of 13,05,400 new equity shares increases the tradeable float of Vipul Organics Limited. However, the majority of shares (approximately 12,05,400 out of 13,05,400) are under lock-in until October 2026, limiting immediate supply impact on the market. The free-float addition is therefore minimal in the near term. This is a routine corporate action with low broader market significance.

Impact Justification

Routine listing of preferentially allotted shares for a small-cap company; limited broader market impact, relevant mainly to existing shareholders and trading members dealing in this scrip.